Stanford Neuromodulation Therapy (SNT) for Non-suicidal Self-injury (NSSI)
China40 participantsStarted 2023-08-01
Plain-language summary
To investigate the treatment effect of Stanford Neuromodulation Therapy (SNT) on patients with Non-suicidal Self-injury (NSSI) and the underlying neural mechanism.
Who can participate
Age range12 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* the patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months
* 12-18 years of age
* The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level
Exclusion Criteria:
* the patients has suicidal ideation, or have committed suicidal behavior
* T1 or T2 weighted phase magnetic resonance images show focal brain lesions
* patients had neurological disorders such as epilepsy, or serious physical illnesses
* patients had history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months
* patiens had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months, or received electroconvulsive therapy in the last 6 months
* patients had previous significant head trauma or with EEG abnormality in the last 1 month
* body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves and other metal implants.